Global Health Initiatives for Schools: Protecting Parental Rights and Privacy
The WHO is expanding its "health promoting schools" initiative globally to provide medical services to children and combat misinformation. Critics...
Health Reset
Secrecy and Mistrust: The Controversial Retraction of a COVID-19 Vaccine Study
An investigation by journalist Rebekah Barnett suggests that politics and financial interests, rather than scientific concerns, led to the retraction...
Unveiling the Hidden Risks: Dr. Christensen on the Covid Vaccines and its Danger
Dr. Margaret Christensen connects COVID-19 vaccines to hormonal disruptions and various health issues, including infertility, miscarriages, and fetal deaths. She...
The Push for New COVID-19 Vaccines Amid Safety Concerns and Low Case Rates
The FDA’s vaccine advisory committee unanimously recommended a monovalent JN.1-lineage COVID-19 vaccine for the 2024-2025 formula despite low COVID-19 hospitalization...
The Uncharted Risks of Repeated COVID-19 mRNA Vaccinations
This article denounces Professor Michael Plank's recommendation for additional COVID-19 mRNA vaccines, highlighting concerns over safety and efficacy, particularly with...
A Whistleblower’s Brave Stand for Transparency in Pfizer’s Vaccine Development
Melissa McAtee, a whistleblower from Pfizer, exposed internal issues, including the use of graphene oxide in COVID-19 vaccines and the...
Ethical Breach in Gardasil Trials Raises Safety Concerns
This study issued in the International Journal of Risk & Safety in Medicine found that Merck's Gardasil clinical trials in...
The Rise in ADHD Diagnoses Among U.S. Children
A CDC study published in the Journal of Clinical Child & Adolescent Psychology reveals that 11.4% of U.S. children aged...
Urgency vs. Safety: The Rush for the Bird Flu Vaccines
This article talks about how the U.S. government is nearing an agreement to fund a late-stage trial of Moderna’s mRNA...
US FDA Approves Moderna’s mRNA RSV Shot Without Consulting Independent Advisers
The US Food and Drug Administration (US FDA) has approved Moderna’s mRNA respiratory syncytial virus (RSV) vaccine for adults 60...